Is Oculis Holding AG halal to invest in?

According to Musaffa's Shariah screening methodology, Oculis Holding AG (OCS) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Oculis Holding AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Oculis Holding AG using these criteria to determine its compliance status.

Can Muslims buy shares of Oculis Holding AG?

Muslim investors may consider investing in Oculis Holding AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Oculis Holding AG classified as NOT HALAL?

Musaffa determines the Shariah status of Oculis Holding AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Oculis Holding AG updated?

The Shariah compliance status of Oculis Holding AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Oculis Holding AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Oculis Holding AG?

You can check the latest Shariah compliance status of Oculis Holding AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

OCS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 16, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Oculis Holding AG (OCS)

Based on 15 analysts giving stock ratings to Oculis Holding AG in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Oculis Holding AG. Stock Analysis OCS

United States Health Care Small Cap Report: 2025 Annual

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 60 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Key Statistics of Oculis Holding AG (OCS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$29.50$30.56

Today's Open

$29.89

Volume

250.91K

P/E Ratio (TTM)

52 Week Range

$16.00$34.48

Market Cap

1.59B

Avg. Volume

473.84K

Dividend Yield

Financial Metrics & Statements of Oculis Holding AG (OCS)

FAQ's for Oculis Holding AG (OCS)

According to Musaffa’s Shariah screening methodology, Oculis Holding AG (OCS) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.